NCT00286208View on ClinicalTrials.gov

Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation

NACompletedINTERVENTIONAL

Enrollment

1,443

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Induced Abortion

Interventions

DRUG

Mifepristone, misoprostol

Trial Locations (9)

Unknown

State University of Medicine and Pharmacy, Chisinau

Centre de Planification Familiale de l'Ariana, Aryanah

Centre de Planification Familiale la Bardo, Tunis

Maternité de La Rabta, Tunis

Private clinic, Tunis

Dr. Zekai Tahir Burak Women's Health Training and Research Hospital, Ankara

MoH Ankara Etlik Maternity and Gyneacological Training Hospital, Ankara

Haydarpaşa Numune Training and Research Hospital Family Planning Clinic, Istanbul

Ege Maternity and Gyneacological Training and Research Hospital, Izmir

All Listed Sponsors

lead

Gynuity Health Projects

OTHER

NCT00286208 - Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation | Biotech Hunter | Biotech Hunter